Clinical Trials on Degeneración macular

Total 53675 results

Jarding, John, OD
i-Lumen Scientific, Inc.; Professor Timothy Jackson, King's College

Completed

Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

Age-Related Macular Degeneration | Nonexudative Age-related Macular Degeneration
Janssen Research & Development, LLC

Completed

AAVCAGsCD59 for the Treatment of Wet AMD

Wet Age-related Macular Degeneration

United States
Moorfields Eye Hospital NHS Foundation Trust
Medical Research Council

Completed

Production of iPSC Derived RPE Cells for Transplantation in AMD

Age Related Macular Degeneration (AMD)
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

Age-related Macular Degeneration (AMD)

United States
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Age-related Macular Degeneration (AMD)

United States
Novartis Pharmaceuticals

Completed

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Age-related Macular Degeneration (AMD)

United States
RemeGen Co., Ltd.

Completed

Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Alkahest, Inc.

Completed

Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration

Wet Age-related Macular Degeneration

Hungary
University Hospital, Limoges

Unknown

Assessment of the Knowledge and Needs of Patients With AMD Before a Therapeutic Patient Education Program is Put in Place (DEMELE)

Age-related Macular Degeneration (AMD)

France
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Medical University of Lublin

Completed

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Exudative Age-related Macular Degeneration
National Eye Institute (NEI)

Completed

AMD Phenotype and Genotype Study

Age-Related Macular Degeneration | AMD

United States, Germany
Chinese Academy of Sciences
Beijing Tongren Hospital

Unknown

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Dry Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD) (UNRAVEL)

Neovacular Age-related Macular Degeneration

Taiwan, Thailand, Israel, Korea, Republic of, Philippines, Singapore, Malaysia
Pfenex, Inc

Completed

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

Age Related Macular Degeneration (AMD)

New Zealand
Affordance
Drescode

Completed

Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation

Exudative Age-related Macular Degeneration

France
Medical University of Vienna

Completed

Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone

Neovascular Age Related Macular Degeneration
MacuCLEAR, Inc.

Completed

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Nonexudative Age-related Macular Degeneration

United States
Merry, Graham, M.D.

Completed

Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration (TORPA)

Nonexudative Age-related Macular Degeneration

United States, Canada
Apheresis Research Institute

Completed

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial (ART)

Dry Age Related Macular Degeneration

Germany
Shahid Beheshti University of Medical Sciences

Unknown

Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

Neovascular Age-Related Macular Degeneration

Iran, Islamic Republic of
Perceive Biotherapeutics, Inc.

Recruiting

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

Australia, Israel
Benobio Co., Ltd.

Not yet recruiting

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Australia
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
Sylentis, S.A.

Recruiting

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Macular Degeneration | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration

Czechia, Slovakia, Poland
OKKO Health

Recruiting

OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration

Age-Related Macular Degeneration

United Kingdom
OcuDyne, Inc.

Recruiting

OcuDyne System in the Treatment of AMD

Age-Related Macular Degeneration

Argentina
Icahn School of Medicine at Mount Sinai
University of California, Los Angeles; National Eye Institute (NEI)

Recruiting

Snapshot Camera for AMD

Age Related Macular Degeneration

United States
National Eye Institute (NEI)

Recruiting

Dark Adaptation in Participants With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Medical University of Vienna

Recruiting

Non-invasive Optical Angiography in Age-related Macular Degeneration

Age Related Macular Degeneration

Austria
Medical University of Vienna

Recruiting

The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Subjects

Age-Related Macular Degeneration

Austria
National Eye Institute (NEI)

Recruiting

Study of Dark Adaptation in Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
The University of Hong Kong

Completed

Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Age-Related Macular Degeneration

Hong Kong
Oxford BioMedica

Active, not recruiting

A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Duke University
Genentech, Inc.

Completed

AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study (A2ASDOCT)

Age Related Macular Degeneration

United States
University Hospital Inselspital, Berne

Active, not recruiting

The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)

Age Related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Completed

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment (FLOS)

Age Related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Completed

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Age Related Macular Degeneration

Switzerland
The Filatov Institute of Eye Diseases and Tissue...
Odessa National Medical University; Mykolaiv Region Ophthalmogical Hospital; Central...

Completed

Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment (COAST_UA_AMD)

Age-Related Macular Degeneration

Ukraine
AngioLab, Inc.

Completed

Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD

Age-Related Macular Degeneration

Korea, Republic of
University of Faisalabad

Completed

Effectiveness of Prism Spectacles in Patients With Age Related Macular Degeneration

Age-Related Macular Degeneration

Pakistan
Centre Hospitalier Universitaire de Nice

Completed

Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration (TARMAC-1)

Age Related Macular Degeneration

France
Laboratoires Thea

Completed

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Age Related Macular Degeneration

France
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Beovu Experience UZ Leuven (BEL)

Age-Related Macular Degeneration

Belgium
Duke University
Bausch & Lomb Incorporated

Completed

Photodynamic Therapy for PDA in NV AMD

Macular Degeneration | Neovascular Age-related Macular Degeneration

United States
LumiThera, Inc.

Completed

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration (ELECTROLIGHT)

Age Related Macular Degeneration

United States
Shahid Beheshti University of Medical Sciences
Harvard Medical School (HMS and HSDM); Swiss Eye Institute

Active, not recruiting

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Age Related Macular Degeneration

Iran, Islamic Republic of

Clinical Trials on Degeneración macular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations